Table 1.
Patient Demographics
| Demographic (n = 114) | Number |
|---|---|
| Age, median (interquartile range), years | 53 (19–84) |
| Age category, n (%), years | |
| ȃ19–44 | 33 (29) |
| ȃ45–64 | 58 (51) |
| ȃ65+ | 23 (20) |
| Sex, n (%), female | 58 (51) |
| Ethnicity, n (%) | |
| ȃCaucasian | 84 (74) |
| ȃAsian | 7 (6) |
| ȃBlack | 7 (6) |
| ȃOther | 16 (14) |
| Solid organ transplanted, n (%) | |
| ȃKidney | 43 (38) |
| ȃLung | 16 (14) |
| ȃLiver | 19 (17) |
| ȃHeart | 17 (15) |
| ȃMultiorgan | 5 (4) |
| Other immunocompromised patients, n (%) | 14 (12) |
| ȃAllogeneic stem cell transplantation on immunosuppressive therapy | 5 (4) |
| ȃAnti-CD20 for underlying hematological disease | 3 (3) |
| ȃAnti-CD20 for autoimmune disease | 5 (4) |
| ȃAnti-CD20 for other disease | 1 (1) |
| Time from transplantation (if transplanted), n (%), years | |
| ȃ<1 | 13 (12) |
| ȃ1–5 | 38 (36) |
| ȃ>5 | 55 (52) |
| Clinical frailty score, n (%) | |
| ȃUnknown | 13 (11) |
| ȃ1–3 | 74 (65) |
| ȃ4–5 | 23 (20) |
| ȃ>5 | 4 (4) |
| Outpatient diagnosis, n (%) | 104 (91) |
| Severe acute respiratory syndrome coronavirus 2 infection, n (%) | |
| ȃProbable Omicron (start of symptoms after 9 January 2022) | 62 (54) |
| ȃProven Omicron | 52 (46) |
| ȃȃBA.1 | 44 (85) |
| ȃȃBA.2 | 2 (4) |
| ȃȃLineage unknown | 6 (11) |